Preliminary suggestions for rigorous GPAI model evaluations
Not on the map. Why?
Abstract (arXiv)
This document presents a preliminary compilation of general-purpose AI (GPAI) evaluation practices that may promote internal validity, external validity and reproducibility. It includes suggestions for human uplift studies and benchmark evaluations, as well as cross-cutting suggestions that may apply to many different evaluation types. Suggestions are organised across four stages in the evaluation life cycle: design, implementation, execution and documentation. Drawing from established practices in machine learning, statistics, psychology, economics, biology and other fields recognised to have important lessons for AI evaluation, these suggestions seek to contribute to the conversation on the nascent and evolving field of the science of GPAI evaluations. The intended audience of this document includes providers of GPAI models presenting systemic risk (GPAISR), for whom the EU AI Act lays out specific evaluation requirements; third-party evaluators; policymakers assessing the rigour of evaluations; and academic researchers developing or conducting GPAI evaluations.
Key facts. Cited by 5 papers in the map (data through 14 Oct 2026). Builds on 5 of its 17 references that are in the map. First posted on arXiv 22 Jul 2025.
Builds on
5 of 17 references.
References · 5
- 2023MLAgentBench: Evaluating Language Agents on Machine Learning Experimentationcited by 366
- 2024AI Agents That Mattercited by 219
- 2020Targeting the Benchmark: On Methodology in Current Natural Language Processing Researchcited by 45
- 2016The State of Applied Econometrics - Causality and Policy Evaluationcited by 41
- 2025What Makes an Evaluation Useful? Common Pitfalls and Best Practicescited by 1
Built on by
Citing papers per year: 2025: 2; 2026: 3.
5 papers.
- 2025STREAM (ChemBio): A Standard for Transparently Reporting Evaluations in AI Model Reportscited by 10
- 2025Against racing to AGI: Cooperation, deterrence, and catastrophic riskscited by 2
- 2026Measuring Biological Capabilities and Risks of AI Agentscited by 1
- 2026RCTs for Frontier AI Governance: Methodological Challenges and Solutions for Human Uplift Studiescited by 0
- 2026Principles and Guidelines for Randomized Controlled Trials in AI Evaluationcited by 0
- 2026Measuring Biological Capabilities and Risks of AI Agents18 Jun 2026
- 2026Principles and Guidelines for Randomized Controlled Trials in AI Evaluation3 May 2026
- 2026RCTs for Frontier AI Governance: Methodological Challenges and Solutions for Human Uplift Studies11 Mar 2026
- 2025STREAM (ChemBio): A Standard for Transparently Reporting Evaluations in AI Model Reports13 Aug 2025
- 2025Against racing to AGI: Cooperation, deterrence, and catastrophic risks29 Jul 2025